tradingkey.logo

Penumbra Inc

PEN

253.370USD

+4.310+1.73%
終値 09/26, 16:00ET15分遅れの株価
9.87B時価総額
66.85直近12ヶ月PER

Penumbra Inc

253.370

+4.310+1.73%
詳細情報 Penumbra Inc 企業名
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
企業情報
企業コードPEN
会社名Penumbra Inc
上場日Sep 18, 2015
最高経営責任者「CEO」Mr. Adam Elsesser, J.D.
従業員数4500
証券種類Ordinary Share
決算期末Sep 18
本社所在地One Penumbra Place
都市ALAMEDA
証券取引所NYSE Consolidated
United States of America
郵便番号94502
電話番号15109952486
ウェブサイトhttps://www.penumbrainc.com/
企業コードPEN
上場日Sep 18, 2015
最高経営責任者「CEO」Mr. Adam Elsesser, J.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
52.28K
-1.13%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
28.25K
--
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.82K
-1.03%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
52.28K
-1.13%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
28.25K
--
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Thrombectomy
226.54M
69.89%
Embolization and Access
97.60M
30.11%
地域別USD
会社名
収益
比率
United States
256.86M
79.24%
International
67.28M
20.76%
事業別
地域別
事業別USD
会社名
収益
比率
Thrombectomy
226.54M
69.89%
Embolization and Access
97.60M
30.11%
株主
更新時刻: Wed, Aug 20
更新時刻: Wed, Aug 20
株主統計
種類
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Global Advisors (US)
3.00%
他の
61.51%
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Global Advisors (US)
3.00%
他の
61.51%
種類
株主統計
比率
Investment Advisor
60.28%
Investment Advisor/Hedge Fund
22.54%
Hedge Fund
5.09%
Individual Investor
3.74%
Pension Fund
1.88%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
0.53%
Private Equity
0.08%
他の
2.99%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
864
37.32M
95.72%
-2.83M
2025Q1
878
36.92M
95.33%
-3.44M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
2023Q1
681
37.31M
97.62%
-964.82K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Fidelity Management & Research Company LLC
4.95M
12.77%
+91.48K
+1.88%
Mar 31, 2025
The Vanguard Group, Inc.
3.67M
9.47%
+24.73K
+0.68%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.53M
9.11%
+30.07K
+0.86%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.18M
3.04%
-58.36K
-4.73%
Mar 31, 2025
State Street Global Advisors (US)
1.20M
3.09%
-5.56K
-0.46%
Mar 31, 2025
Elsesser (Adam)
960.02K
2.48%
+24.15K
+2.58%
Jun 25, 2025
Baillie Gifford & Co.
689.00K
1.78%
-41.24K
-5.65%
Mar 31, 2025
RTW Investments L.P.
862.77K
2.23%
+320.00
+0.04%
Mar 31, 2025
Fidelity Institutional Asset Management
894.92K
2.31%
-70.23K
-7.28%
Mar 31, 2025
Champlain Investment Partners, LLC
869.92K
2.25%
-626.03K
-41.85%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI